Litigation Details for FRESENIUS MEDICAL CARE HOLDINGS, INC. v. SUVEN LIFE SCIENCES, LTD (D.N.J. 2019)
✉ Email this page to a colleague
FRESENIUS MEDICAL CARE HOLDINGS, INC. v. SUVEN LIFE SCIENCES, LTD (D.N.J. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-05-13 |
Court | District Court, D. New Jersey | Date Terminated | 2020-02-17 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Lois H. Goodman |
Patents | 6,576,665; 6,875,445 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FRESENIUS MEDICAL CARE HOLDINGS, INC. v. SUVEN LIFE SCIENCES, LTD
Details for FRESENIUS MEDICAL CARE HOLDINGS, INC. v. SUVEN LIFE SCIENCES, LTD (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-05-13 | 1 | Complaint | expiration of U.S. Patent Nos. 6,576,665 (“the ’665 patent”) and 6,875,445 (“the ’445 patent”) (together, …the assignee of the ’665 patent and the ’445 patent. A copy of the ’665 patent is attached as Exhibit … the ’665 patent and the ’445 patent, and/or because its use is covered by the ’665 patent and the ’445…relief against Suven for patent infringement under the Food and Drug and Patent Laws of the United States…Hatch-Waxman Act”), with respect to the ’665 patent and the ’445 patent, which are both assigned to FMCHI. Under | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |